Background. Blood culture-negative endocarditis (BCNE) may account for up to 31% of all cases of endocarditis.
2.5%-31% of all cases of endocarditis [1] . This variation in incidence may be explained by several factors, including (i) differences in the diagnostic criteria used; (ii) specific epidemiological factors, as for fastidious zoonotic agents; (iii) variations in the early use of antibiotics prior to blood sampling; (iv) differences in sampling strategies [2] ; or (v) involvement of unknown pathogens.
In our laboratory, we have diversified the diagnostic tests used over the past few years for the diagnosis of BCNE. In particular, we have demonstrated the usefulness of systematic serological testing for the detection of fastidious agents, especially Coxiella burnetii and Bartonella species, but also Brucella species, Legionella pneumophila, and Mycoplasma species [2, 3] . Two other methods that exhibited great potential for the diagnosis of BCNE were histological examination [4] and broad-range polymerase chain reaction (PCR), particularly when applied to valvular biopsies [5] . The few studies using PCR for the diagnosis of BCNE published to date have highlighted the importance of streptococci and fastidious bacteria, although their respective prevalence has not been estimated [3, [5] [6] [7] [8] [9] [10] [11] [12] . In addition, among fastidious bacteria, the role of Chlamydia pneumoniae in BCNE remains uncertain, as is the case for viruses [13] . Consequently, diagnosis of BCNE remains a challenge, as highlighted by the 21% rate of cases without any identified causative agent in the largest series of BCNE cases reported to date [3] .
Since our previous publication of a large series of BCNE cases [3] , our laboratory received an increasing number of specimens from patients with BCNE. Here, we prospectively used a comprehensive strategy incorporating a battery of laboratory techniques [3, 5, 14] , including several new ones, to increase the rate of diagnoses in patients with BCNE and to evaluate the prevalence of various agents missed by standard blood cultures, including fastidious bacteria and viruses. We also estimated the incidence of noninfective causes of endocarditis.
PATIENTS AND METHODS

Patients
From 1 June 2001 to 1 September 2009, we prospectively included all patients with suspected BCNE for whom specimens were referred to our laboratory ( Figure 1 and Table 1 ). For each studied patient, a questionnaire was completed by the physician in charge. The questions asked are detailed in Tables  2 and 3 . Answers were not obtained for all questions from all patients. When results of all assays were negative, we recontacted physicians in charge of patients to enquire about any neoplasic or automimmune disease that would have been diagnosed elsewhere. The study was approved by the local ethics committee under reference 07-015. The study was also approved by the Commission Nationale Informatique et Libertés under reference 1223186.
Diagnostic Procedures
Serological analysis. Indirect immunofluorescence assays to detect significant levels of antibodies to C. burnetii (phase I immunoglobulin [Ig] G titer, 11:800), Bartonella quintana, Bartonella henselae (IgG titer, у1:800), and L. pneumophila (total antibody titer, у1:256) were performed as previously described [3] . Specific antibodies to Brucella melitensis and Mycoplasma pneumoniae were detected with an immunoenzymatic antibody test (titer, у1:200) and the Platellia M. pneumoniae IgM kit (Bio-Rad), respectively. Because of a lack of standardization, antibodies to Mycoplasma hominis were not investigated. When results of first-rank tests were negative, we systematically performed Western blot using Bartonella species antigens [16] , as described in the Appendix, which appears only in the electronic version of the journal. Molecular detection methods. Bacterial DNA was extracted from surgically excised valves, or EDTA blood when no valve was available, using the QIAmp Tissue kit (QIAGEN) as described by the manufacturer. PCR primers and targets are detailed in Table 4 , and PCR and sequencing conditions are described in the Appendix. Primer extension enrichment reaction (PEER) was performed on valvular biopsies from patients for whom results of other tests were negative, as previously described [22, 23] . We used the buffy coat obtained from each patient following antibiotic therapy as control tissue ("driver").
Cell culture. Homogenized cardiac valve specimens suitable for culture-that is, frozen at Ϫ80ЊC following surgery and sent in dry ice-and heparinized blood specimens processed in the same way were inoculated onto human endothelial cells (ECV 304) grown in shell vials, as reported elsewhere [24] . Three weeks after inoculation, bacteria detected by Gimenez and acridine orange staining, electron microscopy, or immunofluorescence using the patient's serum, were identified by amplification and sequencing of the 16S rRNA gene as previously described [8] . Histopathological analysis. Paraffin-embedded heart valves were examined with hematoxylin-eosin for histopathologic features [4] . To detect microorganisms within tissues, the Giemsa, Gram (Brown-Brenn and Brown-Hopps), periodic-acid Schiff, Grocott-Gomori, Warthin-Starry, Gimenez, and Ziehl-Nielsen stains were systematically performed as described elsewhere [25] . For patients for whom results of all other techniques remained negative, we performed autoimmunohistochemistry as previously described [26] .
Detection of autoantibodies. Presence of rheumatoid factor, antinuclear antibodies, and anti-DNA antibodies was determined using the Rheumatoid Factor IgM kit (Orgentec), ANA Hep2 kit (BMD), and MuST Connective kit (Inodiag), respectively. 
Statistical Methods
To identify the variables associated with absence of diagnosis, we compared the 476 patients with an identified etiological agent with the 73 definite patients without etiological agents and with the 191 possible patients, using the Mantel-Haenszel x 2 test. Mean ages were compared using the Anova and Bartlett's tests. The variables independently associated with the negativity of all diagnostic tests were identified using an unconditional logistic regression analysis (Tables 2 and 3 and the Supplementary Results in the Appendix). We also compared the diagnoses obtained by our strategy with those of other published BCNE series, using the Mantel-Haenszel x 2 test. All tests were performed using the EPI info software, version 3.3.2 (http://www.cdc.gov/epiinfo/index.htm). Observed differences were considered significant when P was !.05 for 2-tailed tests.
RESULTS
Patients.
Specimens from 819 new patients from France or abroad were included in this study (Figure 1) . By using the modified Duke criteria [15] , 60 patients (7.3%) were excluded from the diagnosis of endocarditis, including 57 who did not meet criteria for possible endocarditis, and 3 for whom histopathological results identified angiosarcoma (2 patients ) and a myxoma of the left atrium (1 patient). Among the remaining 759 patients with endocarditis, 19 (2.5%) were classified as having noninfective endocarditis. Among these, histopathology identified a marantic endocarditis, Libmann-Sacks endocarditis, and Behcet disease in 7, 4, and 1 cases, respectively. Subsequently, by evaluating the presence of antinuclear antibodies of 129 of 290 patients for whom results of all assays were negative and by calling their physicians in charge, we identified an additional 7 patients in whom a diagnosis of autoimmune disease had been done elsewhere using diagnostic criteria [27, 28] , including 5 patients with Libmann-Sacks endocarditis and 2 with rheumatic arthritis. Of the 740 patients putatively classified as having infective endocarditis, 549 (74.2%) were classified as having definite endocarditis using the Duke criteria [15] , including 476 for whom our diagnostic strategy allowed identification of an infectious agent (Table A1 in the online Appendix), and 73 for whom no etiological agent could be found. The remaining 191 patients (25.8%) were classified as possible patients. The epidemiological data of the 740 patients with definite or possible endocarditis are presented in Table 1 .
Diagnostic procedures. Serological analysis using immunofluorescence assay provided a diagnosis for 356 (47.8%) of 745 tested patients (Figure 2 ). Chronic Q fever (IgG titer to phase I C. burnetii, 11:800) was diagnosed in 274 patients (77%). Eighty patients (22.5%) had an IgG titer to B. quintana and/or B. henselae у1:800 (Table A1) . One patient had a titer of 1:2048 to L. pneumophila and a positive result of L. pneumophila urinary antigen assay. One patient had a titer of 1:256 to Legionella anisa and was later diagnosed as having L. longbeachae endocarditis on the basis of both culture and PCR of a valvular biopsy. Among the patients for whom no diagnosis was obtained with other tests, serum was available for Bartonella Western blot for 148 patients. For these patients, a diagnosis of B. quintana infection was obtained for 4 patients who were seronegative using immunofluorescence assay.
Additionally, 16S ribosomal DNA (rDNA) and 18S rDNA PCR assays performed on EDTA blood provided diagnoses for 35 (13.6%) and 1 (0.4%) of 257 patients, respectively. Also, 16S rDNA and 18S rDNA PCR assays of valvular specimens were positive for 150 (66.1%) and 7 (3.0%) of 227 patients, respectively (Table A1 ). PCR amplification of C. burnetii, Bartonella species, and Tropheryma whipplei was positive for 16, 12, and 5 EDTA blood specimens, respectively, and for 30, 26 and 17 valvular biopsies, respectively. Results for negative controls were in all assays. Overall, PCR identified a causative agent in 109 seronegative patients, including 106 by PCR of valvular specimens and 3 by PCR of blood only. PCR assays for cytomegalovirus, enteroviruses, and C. pneumoniae were negative for all tested specimens. PEER, performed on 49 valvular biopsies from patients for whom all other diagnostic methods failed to identify a causative agent, identified a microorganism in 4 patients: Mycobacterium tuberculosis, Micrococcus luteus, Candida dubliniensis, and Cryptococcus laurentii. Sequences obtained from these microorganisms have been deposited in GenBank under accession numbers EU139422, EU139419, EU139420, and EU139421, respectively. Results for negative controls remained negative.
Cell culture of heparinized blood allowed bacterial recovery in 7 (4.1%) of 169 patients. When applied to valvular biopsies, culture was positive for 58 (45.7%) of 127 patients. Culture did not provide any diagnosis that was not made by another method. Detailed results are presented in Table A1 .
Culture and PCR of valvular biopsies (positive for 58 of 127 patients and 157 of 227 patients, respectively) were significantly more sensitive than were culture and PCR of blood (positive for 7 of 169 patients and 36 of 257 patients, respectively; P ! for both). In addition, PCR was significantly more sensitive .01 than was culture for valvular biopsies ( ) (Table 5 ). However, in the latter study, we had P ! .01 considered only patients classified as having definite endocarditis and identified an agent different from C. burnetii and Bartonella species in only 5 patients, compared with 110 patients in the present study ( ). P ! .01 France [3] (n p 348) France [29] (n p 88)
Great Britain [30] (n p 63) Algeria [31] (n p 62) Presence of rheumatoid factor was detected in 73 patients. Among 115 tested patients without diagnosis, antinuclear antibodies were found in 10, including 5 who also had anti-DNA antibodies. By contacting the physicians in charge of these 10 patients, we had confirmation that 5 patients received a diagnosis of systemic lupus erythematosus and 2 received a diagnosis of rheumatic fever.
Histopathological examination of valvular biopsies enabled the diagnosis of an angiosarcoma and a myxoma of the left atrium in 2 and 1 patients, respectively, and a diagnosis of noninfective endocarditis in 12 patients: marantic endocarditis in 7, Libman-Sachs endocarditis in 4, and cardiac involvement of Behcet disease in 1. Valvular and serum specimens suitable for autoimmunohistochemistry were available from 52 patients without any identified etiology. Results were negative except for 1 patient in whom cocci were observed (Figure 3) . However, results of all other tests performed on this surgically excised valve, including PEER, 16S rDNA PCR, and 18S rDNA PCR, remained negative.
DISCUSSION
In the present series, in an effort to increase our detection sensitivity for the diagnosis of BCNE, we used a multimodal diagnostic strategy, including validated methods for the identification of endocarditis agents, assays newly applied for this purpose, and assays for the detection of microorganisms of uncertain role. Our study, in addition to reporting the largest diagnostic series of BCNE to date and the largest series of PCR detection from valvular biopsies, identified a causative microbial agent in 476 (62.7%) of 759 tested patients with BCNE and a high incidence of noninfective endocarditis (2.5%). Our current strategy allowed the identification of a significantly greater variety of etiological agents than was identifed in a previous series from our laboratory ( ) [3] . However, new P ! .01 techniques introduced in this study to detect new agents, such as autoimmunohistochemistry and PEER, were disappointing.
Apart from serological analysis by immunofluorescence assay, which provided the greatest number of diagnoses (356 [74.8%] of 476) (Table A1) , PCR was the second most efficient diagnostic method and provided a diagnosis for 109 patients for whom serological results were negative. However, the PCR output varied depending on specimens. When applied to blood, 16S rRNA amplification exhibited a poor sensitivity, with 35 positive specimens of 257 tested (13.6%). This low sensitivity was also recently reported by Casalta et al [32] . In contrast, dedicated real-time PCR assays targeting small DNA fragments and using fluorescent probes exhibited a high sensitivity for Bartonella species, C. burnetii, and T. whipplei, as previously described [33] . However, in our study, PCR of blood did not provide any additional diagnosis of Q fever with regard to serological analysis. Therefore, our data suggest that dedicated real-time PCR assays, in particular those targeting Bartonella species and T. whipplei, might be valuable for use on EDTA blood, in particular for patients for whom valvular biopsies are not available. In addition, by using a broad-range, 18S rRNAbased PCR assay targeting fungi, we identified a Penicillium species as an agent in a patient. To date, PCR assays targeting fungi have been used in a limited number of studies [9, 11] . Given the fact that these agents are not covered by most empirical antibiotic therapies used for BCNE, we propose that this assay should form part of the diagnostic strategy for BCNE.
Valvular biopsies, when available, proved to be of great diagnostic value, allowing the detection of a microorganism in 157 patients. The 16S rDNA and 18S rDNA PCR assays of valves were positive for 150 (66.1%) and 7 (3.0%) of 227 patients, respectively (Table A1) . In recent studies, broad-range PCR for bacteria was demonstrated to be highly valuable for valvular specimens [3, [6] [7] [8] [9] [10] [11] 14] , with the identification of streptococci and fastidious bacteria as main agents (Table 5 ).
In our study, the main bacterial agents identified by PCR were streptococci (mainly Streptococcus gallolyticus), T. whipplei, Bartonella species, and staphylococci. These diagnoses suggest that, unlike for blood specimens, broad-range PCR may be preferred as the first-line test for valvular specimens. We detected no viral agent or Chlamydia species. Among assays newly applied for this purpose, Western blot for Bartonella species, PEER, and autoimmunohistochemistry provided a diagnosis for 4, 4, and 1 patients, respectively, for whom results of all other methods were negative. Such findings suggest that these methods should be considered only when others fail.
Of the identified agents, zoonotic bacteria were the most frequent (Supplementary Comments and Table A1 in the Ap-pendix). C. burnetii was the main identified etiological agent (57.3%), followed by Bartonella species (19.2%). Because we acknowledge the fact that this prevalence may be caused by a sampling bias, we differentiated patients from Marseille and those from other hospitals (Table A1) . In both populations, C. burnetii and Bartonella species were predominant, accounting for 46.0% and 15.1% of identified agents in Marseille, respectively, and for 61.4% and 20.7% of identified agents in other hospitals, respectively. Such results confirm the role of C. burnetii as a major agent of BCNE in France and other countries [29, 30, 34, 35] , followed by Bartonella species. For these agents, the diagnosis was mostly obtained by serological analysis, which demonstrates the necessity to systematically include antibody detection for C. burnetii and Bartonella species in the diagnosis of BCNE (Figure 2 ) [36] . Other fastidious bacteria, such as T. whipplei (4.0%), Legionella species (0.4%), mycobacteria (0.4%), M. hominis (0.2%), Gemella morbillorum (0.2%), and Abiotrophia defectiva (0.2%) accounted for 5.4% of identified agents. Fungi were identified in 8 patients (1.7%). In previous series of BCNE, fungi accounted for up to 6.3% of patients [30] , which suggests the need to systematically search for these microorganisms in BCNE. The usual bacteria that may have been inactivated by early antibiotic therapy, in particular streptococci (6.9%) and staphylococci (3.1%), accounted for 16.5% of cases. The role of antibiotics in the absence of diagnosis, well-recognized in previous studies [37] [38] [39] , was emphasized by our statistical analysis ( ) (Table 3 ). Among strepto-P ! .01 cocci, S. gallolyticus was the main species (1.9% of microorganisms), exclusively detected in elderly patients.
An unexpected finding of our study was the identification of 19 patients with noninfective endocarditis, including 7 cases of marantic and 9 cases of Libmann-Sacks endocarditis. As a matter of fact, in a preliminary study, the demonstration of a significant association between an elevated rheumatoid factor rate and absence of diagnosis, as observed in our statistical analysis ( ) (Table 3) , motivated us to evaluate the pres-P ! .01 ence of antinuclear antibodies and to call physicians of patients without identified etiology and enabled the retrospective identification of 5 more patients with systemic lupus erythematosus and 2 with rheumatoid arthritis. These data demonstrate that the BCNE picture may include cases of nonbacterial thrombotic endocarditis associated with cancers and autoimmune diseases [4, [40] [41] [42] . To the best of our knowledge, the prevalence of noninfective etiologies of endocarditis has not previously been evaluated. In our study, noninfective endocarditis accounted for 2.5% of cases of BCNE. Our results support the usefulness of a systematic detection of rheumatoid factor and antinuclear antibodies, as well as histopathological analysis of all valvular biopsies taken from patients with suspected endocarditis.
On the basis of our results, we propose a refined strategy for the diagnosis of BCNE (Figure 2 ). Serum should be considered a priority specimen, with Q fever and Bartonella serological analysis being systematic, followed by specific PCR assays for Bartonella species, T. whipplei, and fungi. Other serological analyses, Bartonella-specific Western blot, and broad-range PCR of blood [32] should be reserved for patients with negative results. We also suggest that detection of antinuclear antibodies and rheumatoid factor should be systematic [43] . When available, valvular biopsies should first be tested using broad-range PCR assays for bacteria and fungi, with autoimmunohistochemistry being reserved for patients without any identified diagnosis. Finally, given the poor sensitivity of commercially available PCR kits for detection in blood [32] , we believe that highly sensitive PCR assays specifically targeting staphylococci and streptococci, in particular S. gallolyticus, may be valuable detection tools for blood specimens in the future.
